• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Benign prostatic hyperplasia: counting the cost of its management.

作者信息

Kirby Roger S, Kirby Mike, Fitzpatrick John M

机构信息

The Prostate Centre, London, UK.

出版信息

BJU Int. 2010 Apr;105(7):901-2. doi: 10.1111/j.1464-410X.2010.09274.x.

DOI:10.1111/j.1464-410X.2010.09274.x
PMID:20356323
Abstract
摘要

相似文献

1
Benign prostatic hyperplasia: counting the cost of its management.良性前列腺增生症：计算其治疗成本
BJU Int. 2010 Apr;105(7):901-2. doi: 10.1111/j.1464-410X.2010.09274.x.
2
The management of benign prostatic obstruction: a voice from the Third World.良性前列腺梗阻的管理：来自第三世界的声音。
BJU Int. 2006 Apr;97(4):671-2. doi: 10.1111/j.1464-410X.2006.06062.x.
3
A clinical outcomes and cost analysis comparing photoselective vaporization of the prostate to alternative minimally invasive therapies and transurethral prostate resection for the treatment of benign prostatic hyperplasia.一项关于前列腺光选择性汽化术与其他微创治疗方法及经尿道前列腺切除术治疗良性前列腺增生的临床结果和成本分析。
J Urol. 2006 Oct;176(4 Pt 1):1500-6. doi: 10.1016/j.juro.2006.06.064.
4
Cost-effectiveness of new treatments for benign prostatic hyperplasia: results of a randomized trial comparing the short-term cost-effectiveness of transurethral interstitial laser coagulation of the prostate, transurethral microwave thermotherapy and standard transurethral resection or incision of the prostate.良性前列腺增生症新疗法的成本效益：一项随机试验的结果，比较前列腺经尿道间质激光凝固术、经尿道微波热疗与标准经尿道前列腺切除术或前列腺切开术的短期成本效益。
Scand J Urol Nephrol. 2002;36(4):286-95. doi: 10.1080/003655902320248263.
5
A cost comparison of medical management and transurethral needle ablation for treatment of benign prostatic hyperplasia during a 5-year period.5年期内药物治疗与经尿道针刺消融治疗良性前列腺增生的成本比较。
J Urol. 2005 Jun;173(6):2090-3; discussion 2093. doi: 10.1097/01.ju.0000158451.30419.66.
6
Durability and cost-effectiveness of transurethral needle ablation of the prostate as an alternative to transurethral resection of the prostate when alpha-adrenergic antagonist therapy fails.当α-肾上腺素能拮抗剂治疗失败时，经尿道前列腺针刺消融术作为经尿道前列腺切除术的替代方法的耐用性和成本效益。
J Urol. 2007 Mar;177(3):1047-51; discussion 1051. doi: 10.1016/j.juro.2006.10.042.
7
Benign prostatic hyperplasia: counting the cost of its management.良性前列腺增生症：计算其治疗成本
BJU Int. 2010 Aug;106(4):586. doi: 10.1111/j.1464-410X.2010.09551_2.x.
8
Transurethral resection vs microwave thermotherapy of the prostate: a cost-consequences analysis.经尿道前列腺切除术与前列腺微波热疗：成本-后果分析
BJU Int. 2004 May;93(7):1118-9. doi: 10.1111/j.1464-410X.2004.4834i.x.
9
An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia.良性前列腺增生症治疗的经济成本及与患者相关后果的评估。
BJU Int. 2006 May;97(5):1007-16. doi: 10.1111/j.1464-410X.2005.06089.x. Epub 2006 Mar 17.
10
Long-term cost analysis of treatment options for benign prostatic hyperplasia in Norway.挪威良性前列腺增生治疗方案的长期成本分析
Scand J Urol Nephrol. 2007;41(2):124-31. doi: 10.1080/00365590600911266.

引用本文的文献

1
Real-world therapeutic management and evolution of patients with benign prostatic hyperplasia in primary care and urology in Spain.西班牙初级保健和泌尿科中良性前列腺增生患者的真实世界治疗管理和演变。
Int J Clin Pract. 2021 Aug;75(8):e14250. doi: 10.1111/ijcp.14250. Epub 2021 May 29.
2
Anticholinergics combined with alpha-blockers for treating lower urinary tract symptoms related to benign prostatic obstruction.抗胆碱能药物联合α-受体阻滞剂治疗良性前列腺增生相关下尿路症状。
Cochrane Database Syst Rev. 2021 Feb 10;2(2):CD012336. doi: 10.1002/14651858.CD012336.pub2.
3
Real-world assessment and characteristics of men with benign prostatic hyperplasia (BPH) in primary care and urology clinics in Spain.
西班牙初级保健诊所和泌尿科诊所中良性前列腺增生（BPH）男性患者的真实世界评估和特征。
Int J Clin Pract. 2020 Nov;74(11):e13602. doi: 10.1111/ijcp.13602. Epub 2020 Aug 16.
4
A Prospective Study of Physical Activity, Sedentary Behavior, and Incidence and Progression of Lower Urinary Tract Symptoms.一项体力活动、久坐行为与下尿路症状发生和进展关系的前瞻性研究。
J Gen Intern Med. 2020 Aug;35(8):2281-2288. doi: 10.1007/s11606-020-05814-1. Epub 2020 Apr 28.
5
Bipolar versus monopolar transurethral resection of the prostate for lower urinary tract symptoms secondary to benign prostatic obstruction.双极与单极经尿道前列腺切除术治疗良性前列腺梗阻继发的下尿路症状
Cochrane Database Syst Rev. 2019 Dec 3;12(12):CD009629. doi: 10.1002/14651858.CD009629.pub4.
6
Costs of Managing Benign Prostatic Hyperplasia in the Office and Operating Room.门诊及手术室中良性前列腺增生的管理成本。
Curr Urol Rep. 2018 Jul 19;19(9):72. doi: 10.1007/s11934-018-0822-z.
7
Resource utilization and costs associated with the addition of an antimuscarinic in patients treated with an alpha-blocker for the treatment of urinary symptoms linked to benign prostatic hyperplasia.在使用α受体阻滞剂治疗与良性前列腺增生相关的泌尿症状的患者中，加用抗毒蕈碱药物的资源利用情况及成本。
BMC Urol. 2017 Sep 12;17(1):83. doi: 10.1186/s12894-017-0275-6.
8
Factors related to receipt of non-cancer-related transurethral prostatectomy: findings from a large prospective study of 106 769 middle-aged and older Australian men.与非癌症相关的经尿道前列腺切除术相关的因素：来自对 106769 名澳大利亚中老年男性进行的一项大型前瞻性研究的结果。
BMJ Open. 2017 Feb 8;7(2):e013737. doi: 10.1136/bmjopen-2016-013737.
9
Understanding patient and physician perceptions of benign prostatic hyperplasia in Asia Pacific, Latin America and the Commonwealth of Independent States: the Prostate Research on Behaviour and Education (PROBE) II survey.了解亚太地区、拉丁美洲和独立国家联合体患者及医生对良性前列腺增生的认知：行为与教育前列腺研究（PROBE）II调查
Int J Clin Pract. 2016 Oct;70(10):870-880. doi: 10.1111/ijcp.12879.
10
Cost of illness of medically treated benign prostatic hyperplasia in Hungary.匈牙利药物治疗良性前列腺增生症的疾病成本。
Int Urol Nephrol. 2015 Aug;47(8):1241-9. doi: 10.1007/s11255-015-1028-7. Epub 2015 Jun 21.